A share price of NRX Pharmaceuticals Inc [NRXP] is currently trading at $1.93, saw in change for the day. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The NRXP shares have gain 7.82% over the last week, with a monthly amount drifted -11.47%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
NRX Pharmaceuticals Inc [NASDAQ: NRXP] stock has seen the most recent analyst activity on April 02, 2025, when BTIG Research initiated its Buy rating and assigned the stock a price target of $18.
NRX Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $1.10 and $6.01. Currently, Wall Street analysts expect the stock to reach $2 within the next 12 months. NRX Pharmaceuticals Inc [NASDAQ: NRXP] shares were valued at $1.93 at the most recent close of the market. An investor can expect a potential return of 3.63% based on the average NRXP price forecast.
Analyzing the NRXP fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -6.88, Equity is 1.33 and Total Capital is 1.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of-0.28.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.8933 points at the first support level, and at 1.8567 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.9633, and for the 2nd resistance point, it is at 1.9967.
Ratios To Look Out For
To put it in perspective, the Current Ratio for NRX Pharmaceuticals Inc [NASDAQ:NRXP] is 0.15. In addition, the Quick Ratio stands at 0.15 and the Cash Ratio stands at 0.07.
Transactions by insiders
Recent insider trading involved Javitt Jonathan C, Chairman and Chief Scientist, that happened on Dec 17 ’24 when 40000.0 shares were purchased.
